Spanning over 1,000 km, "Shudao," or the roads of the Shu Kingdom, winds through rugged mountains and turbulent streams, ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...

美国食品药品管理局 (FDA) 已批准 Evrysdi ® (risdiplam)片剂用于治疗脊髓性肌萎缩症 (SMA)。此前，该治疗药物仅以粉末形式提供，需要由医疗保健提供者在配药前 将其调配成口服溶液。

归属于上市公司股东的净利润为13.87亿元，较2023年的14.43亿元同比下降3.90%。净利润下滑主要受营收下降以及研发投入增加等因素影响。公司在创新药研发上持续发力，2024年研发费用达到14.35亿元，同比虽有下降但仍处于较高水平，对净利润造成一定压力。